Healthcare Triangle to Acquire TeyameAI to Boost AIDriven Global Patient Engagement Platform
Reuters
Oct 09, 2025
Healthcare Triangle to Acquire TeyameAI to Boost AIDriven Global Patient Engagement Platform
Healthcare Triangle Inc. has signed a non-binding Letter of Intent to acquire the assets of Teyame.AI LLC, a Spain-based company specializing in AI-powered omnichannel customer experience solutions. The proposed acquisition would bring Teyame's advanced AI automation platform under Healthcare Triangle's umbrella, with the aim of creating a next-generation global customer engagement ecosystem for healthcare. Teyame is projected to generate approximately $34 million in revenue and $4.2 million in EBITDA for fiscal year 2025. The integration is expected to enable intelligent automation for treatment plans, chronic care workflows, and patient outreach, while also expanding Healthcare Triangle's reach into international markets and enhancing its innovation team with Teyame's AI and automation experts.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via CNW (Ref. ID: C9982) on October 09, 2025, and is solely responsible for the information contained therein.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.